Hypoglycemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Hypoglycemia is a condition characterized by an abnormally low level of blood sugar (glucose). Symptoms of hypoglycemia include tachycardia, anxiety, shaking, irritability, feelings of hunger, weakness, tiredness, dizziness, headache, confusion, and trouble concentrating. Risk factors include drug or alcohol consumption, older age, longer duration of diabetes, renal disease, peripheral neuropathy, obesity, and cognitive dysfunction.
The Hypoglycemia drugs in development market research report provide comprehensive information on the therapeutics under development for Hypoglycemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Hypoglycemia and features dormant and discontinued projects.
Key Targets in the Hypoglycemia Pipeline Products Market
The key targets in the Hypoglycemia pipeline products market are Glucagon Receptor, Glucagon Like Peptide 1 Receptor, Glucose Dependent Insulinotropic Receptor, Insulin Receptor, Sodium/Glucose Cotransporter 2, and Somatostatin Receptor Type 2.
Hypoglycemia Pipeline Products Analysis Market by Targets
For more target insights, download a free report sample
Key Mechanisms of Action in the Hypoglycemia Pipeline Products Market
The key mechanisms of action in the Hypoglycemia pipeline products market are Glucagon Receptor Agonist, Glucagon Like Peptide 1 Receptor Antagonist, Glucose Dependent Insulinotropic Receptor Agonist, Insulin Receptor Antagonist, Sodium/Glucose Cotransporter 2 Inhibitor, and Somatostatin Receptor Type 2 Antagonist.
Hypoglycemia Pipeline Products Market Analysis by Mechanism of Actions
For more mechanism of actions insights, download a free report sample
Key Routes of Administration in the Hypoglycemia Pipeline Products Market
The key routes of administration in the Hypoglycemia pipeline products market are subcutaneous, intravenous, intramuscular, oral, parenteral, and transdermal.
Hypoglycemia Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the Hypoglycemia Pipeline Products Market
The key molecule types in the Hypoglycemia pipeline products market are recombinant peptide, synthetic peptide, monoclonal antibody, and small molecule.
Hypoglycemia Pipeline Products Market Analysis by Molecule Type
For more molecule type insights, download a free report sample
Major Companies in the Hypoglycemia Pipeline Products Market
Some of the major companies in the Hypoglycemia pipeline products market are LATITUDE Pharmaceuticals Inc, Avolynt Inc, Boehringer Ingelheim International GmbH, Covis Pharmaceuticals Inc, CymaBay Therapeutics Inc, Eiger BioPharmaceuticals Inc, NB Health Laboratory Co Ltd, Protomer Technologies Inc, Rezolute Inc, and Twist Bioscience Corp.
Hypoglycemia Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
Market Report Overview
Key targets | Glucagon Receptor, Glucagon Like Peptide 1 Receptor, Glucose Dependent Insulinotropic Receptor, Insulin Receptor, Sodium/Glucose Cotransporter 2, and Somatostatin Receptor Type 2 |
Key mechanism of action | Glucagon Receptor Agonist, Glucagon Like Peptide 1 Receptor Antagonist, Glucose Dependent Insulinotropic Receptor Agonist, Insulin Receptor Antagonist, Sodium/Glucose Cotransporter 2 Inhibitor, and Somatostatin Receptor Type 2 Antagonist |
Key routes of administration | Subcutaneous, Intravenous, Intramuscular, Oral, Parenteral, and Transdermal |
Key molecule type | Recombinant Peptide, Synthetic Peptide, Monoclonal Antibody, and Small Molecule |
Major companies | LATITUDE Pharmaceuticals Inc, Avolynt Inc, Boehringer Ingelheim International GmbH, Covis Pharmaceuticals Inc, CymaBay Therapeutics Inc, Eiger BioPharmaceuticals Inc, NB Health Laboratory Co Ltd, Protomer Technologies Inc, Rezolute Inc, and Twist Bioscience Corp |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Hypoglycemia (Metabolic Disorders).
- The pipeline guide reviews pipeline therapeutics for Hypoglycemia (Metabolic Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Hypoglycemia (Metabolic Disorders) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Hypoglycemia (Metabolic Disorders) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Hypoglycemia (Metabolic Disorders)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Hypoglycemia (Metabolic Disorders).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Hypoglycemia (Metabolic Disorders) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
Boehringer Ingelheim International GmbH
Covis Pharmaceuticals Inc
CymaBay Therapeutics Inc
Eiger BioPharmaceuticals Inc
LATITUDE Pharmaceuticals Inc
NB Health Laboratory Co Ltd
Protomer Technologies Inc
Rezolute Inc
Twist Bioscience Corp
USV Pvt Ltd
Xeris Biopharma Holdings Inc
Zealand Pharma AS
Zosano Pharma Corp
Zucara Therapeutics Inc
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Hypoglycemia products market?
The key targets in the Hypoglycemia pipeline products market are Glucagon Receptor, Glucagon Like Peptide 1 Receptor, Glucose Dependent Insulinotropic Receptor, Insulin Receptor, Sodium/Glucose Cotransporter 2, and Somatostatin Receptor Type 2.
-
What are the key mechanisms of action in the Hypoglycemia pipeline products market?
The key mechanisms of action in the Hypoglycemia pipeline products market are Glucagon Receptor Agonist, Glucagon Like Peptide 1 Receptor Antagonist, Glucose Dependent Insulinotropic Receptor Agonist, Insulin Receptor Antagonist, Sodium/Glucose Cotransporter 2 Inhibitor, and Somatostatin Receptor Type 2 Antagonist.
-
What are the key routes of administration in the Hypoglycemia pipeline products market?
The key routes of administration in the Hypoglycemia pipeline products market are subcutaneous, intravenous, intramuscular, oral, parenteral, and transdermal.
-
What are the key molecule types in the Hypoglycemia pipeline products market?
The key molecule types in the Hypoglycemia pipeline products market are recombinant peptide, synthetic peptide, monoclonal antibody, and small molecule.
-
Which are the major companies in the Hypoglycemia pipeline products market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.